NCT00434161 · BASELINE

Baseline characteristics

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma · Source last updated 2015-03-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
109
group Id
BG001
value
57
group Id
BG002
value
115
group Id
BG003
value
281
units
Participants

groups

description
Subjects to receive palifermin before-high dose chemotherapy (total 3 doses) and matched placebo after-high dose chemotherapy (total 3 doses)
id
BG000
title
Palifermin Before Only
description
Subjects to receive matched placebo before- and after-high dose chemotherapy
id
BG001
title
Placebo
description
Subjects to receive palifermin before- and after-high dose chemotherapy (total of 6 doses)
id
BG002
title
Palifermin Before and After
description
Total of all reporting groups
id
BG003
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
0
title
<=18 years
measurements
group Id
BG000
value
90
group Id
BG001
value
49
group Id
BG002
value
100
group Id
BG003
value
239
title
Between 18 and 65 years
measurements
group Id
BG000
value
19
group Id
BG001
value
8
group Id
BG002
value
15
group Id
BG003
value
42
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
8.4
value
55.3
group Id
BG001
spread
7.0
value
57.1
group Id
BG002
spread
7.5
value
56.1
group Id
BG003
spread
7.7
value
56
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
50
group Id
BG001
value
24
group Id
BG002
value
52
group Id
BG003
value
126
title
Female
measurements
group Id
BG000
value
59
group Id
BG001
value
33
group Id
BG002
value
63
group Id
BG003
value
155
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
9
group Id
BG002
value
23
group Id
BG003
value
48
title
Germany
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
9
group Id
BG002
value
16
group Id
BG003
value
47
title
Hungary
categories
measurements
group Id
BG000
value
15
group Id
BG001
value
10
group Id
BG002
value
16
group Id
BG003
value
41
title
France
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
5
group Id
BG002
value
9
group Id
BG003
value
30
title
Austria
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
1
group Id
BG002
value
11
group Id
BG003
value
20
title
Belgium
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
4
group Id
BG002
value
7
group Id
BG003
value
18
title
Czech Republic
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
4
group Id
BG002
value
9
group Id
BG003
value
17
title
Italy
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
5
group Id
BG002
value
6
group Id
BG003
value
15
title
Switzerland
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
2
group Id
BG002
value
5
group Id
BG003
value
11
title
United Kingdom
categories
measurements
group Id
BG000
value
3
group Id
BG001
value
3
group Id
BG002
value
4
group Id
BG003
value
10
title
Finland
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
1
group Id
BG002
value
5
group Id
BG003
value
10
title
Netherlands
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
2
group Id
BG002
value
3
group Id
BG003
value
7
title
Ireland
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

Complete source fields

denoms

counts
group Id
BG000
value
109
group Id
BG001
value
57
group Id
BG002
value
115
group Id
BG003
value
281
units
Participants

groups

description
Subjects to receive palifermin before-high dose chemotherapy (total 3 doses) and matched placebo after-high dose chemotherapy (total 3 doses)
id
BG000
title
Palifermin Before Only
description
Subjects to receive matched placebo before- and after-high dose chemotherapy
id
BG001
title
Placebo
description
Subjects to receive palifermin before- and after-high dose chemotherapy (total of 6 doses)
id
BG002
title
Palifermin Before and After
description
Total of all reporting groups
id
BG003
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
group Id
BG003
value
0
title
<=18 years
measurements
group Id
BG000
value
90
group Id
BG001
value
49
group Id
BG002
value
100
group Id
BG003
value
239
title
Between 18 and 65 years
measurements
group Id
BG000
value
19
group Id
BG001
value
8
group Id
BG002
value
15
group Id
BG003
value
42
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
spread
8.4
value
55.3
group Id
BG001
spread
7.0
value
57.1
group Id
BG002
spread
7.5
value
56.1
group Id
BG003
spread
7.7
value
56
dispersion Type
STANDARD_DEVIATION
param Type
MEAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
50
group Id
BG001
value
24
group Id
BG002
value
52
group Id
BG003
value
126
title
Female
measurements
group Id
BG000
value
59
group Id
BG001
value
33
group Id
BG002
value
63
group Id
BG003
value
155
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
9
group Id
BG002
value
23
group Id
BG003
value
48
title
Germany
categories
measurements
group Id
BG000
value
22
group Id
BG001
value
9
group Id
BG002
value
16
group Id
BG003
value
47
title
Hungary
categories
measurements
group Id
BG000
value
15
group Id
BG001
value
10
group Id
BG002
value
16
group Id
BG003
value
41
title
France
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
5
group Id
BG002
value
9
group Id
BG003
value
30
title
Austria
categories
measurements
group Id
BG000
value
8
group Id
BG001
value
1
group Id
BG002
value
11
group Id
BG003
value
20
title
Belgium
categories
measurements
group Id
BG000
value
7
group Id
BG001
value
4
group Id
BG002
value
7
group Id
BG003
value
18
title
Czech Republic
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
4
group Id
BG002
value
9
group Id
BG003
value
17
title
Italy
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
5
group Id
BG002
value
6
group Id
BG003
value
15
title
Switzerland
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
2
group Id
BG002
value
5
group Id
BG003
value
11
title
United Kingdom
categories
measurements
group Id
BG000
value
3
group Id
BG001
value
3
group Id
BG002
value
4
group Id
BG003
value
10
title
Finland
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
1
group Id
BG002
value
5
group Id
BG003
value
10
title
Netherlands
categories
measurements
group Id
BG000
value
2
group Id
BG001
value
2
group Id
BG002
value
3
group Id
BG003
value
7
title
Ireland
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice